-
1
-
-
0030889653
-
Compliance with treatment regimens in chronic asymptomatic diseases
-
Miller NH. Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med. 1997;102:43-49.
-
(1997)
Am J Med
, vol.102
, pp. 43-49
-
-
Miller, N.H.1
-
2
-
-
0032543545
-
Virological failure and adherence to antiretroviral therapy in HIV-infected patients
-
Rodriguez-Rosado R, Jimenez-Nacher I, Soriano V, et al. Virological failure and adherence to antiretroviral therapy in HIV-infected patients. AIDS. 1998;12:1112-1113.
-
(1998)
AIDS
, vol.12
, pp. 1112-1113
-
-
Rodriguez-Rosado, R.1
Jimenez-Nacher, I.2
Soriano, V.3
-
3
-
-
0041827389
-
High levels of adherence do not prevent accumulation of HIV drug resistance mutations
-
Bangsberg DR, Charlebois ED, Grant RM, et al. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS. 2003;17:1925-1932.
-
(2003)
AIDS
, vol.17
, pp. 1925-1932
-
-
Bangsberg, D.R.1
Charlebois, E.D.2
Grant, R.M.3
-
4
-
-
0034604276
-
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
-
Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
-
(2000)
Ann Intern Med
, vol.133
, pp. 21-30
-
-
Paterson, D.L.1
Swindells, S.2
Mohr, J.3
-
5
-
-
11144236109
-
Similar adherence rates favour different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors
-
Maggiolo F, Ravasio L, Ripamonti D, et al. Similar adherence rates favour different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clin Infect Dis. 2005;40:158-163.
-
(2005)
Clin Infect Dis
, vol.40
, pp. 158-163
-
-
Maggiolo, F.1
Ravasio, L.2
Ripamonti, D.3
-
6
-
-
33748642352
-
Less than 95% adherence to nonnucleoside reverse transcriptase inhibitor therapy can lead to viral suppression
-
Bangsberg D. Less than 95% adherence to nonnucleoside reverse transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43:939-941.
-
(2006)
Clin Infect Dis
, vol.43
, pp. 939-941
-
-
Bangsberg, D.1
-
7
-
-
34247249920
-
Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India
-
Shah B, Walshe L, Saple DG, et al. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Infect Dis. 2007;44:1235-1244.
-
(2007)
Clin Infect Dis
, vol.44
, pp. 1235-1244
-
-
Shah, B.1
Walshe, L.2
Saple, D.G.3
-
8
-
-
36048981531
-
Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI-or PI-treated patients
-
Maggiolo F, Airoldi M, Kleinloog HD, et al. Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI-or PI-treated patients. HIV Clin Trials. 2007;8:282-292.
-
(2007)
HIV Clin Trials.
, vol.8
, pp. 282-292
-
-
Maggiolo, F.1
Airoldi, M.2
Kleinloog, H.D.3
-
9
-
-
33646034630
-
Adherence-resistance relationship for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness
-
Bangsberg DR, Acosta EP, Gupta R, et al. Adherence-resistance relationship for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS. 2006;20:223-231.
-
(2006)
AIDS.
, vol.20
, pp. 223-231
-
-
Bangsberg, D.R.1
Acosta, E.P.2
Gupta, R.3
-
10
-
-
3042842610
-
Modelling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates
-
Bangsberg DR, Porco TC, Kagay C, et al. Modelling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates. J Infect Dis. 2004;190:162-165.
-
(2004)
J Infect Dis
, vol.190
, pp. 162-165
-
-
Bangsberg, D.R.1
Porco, T.C.2
Kagay, C.3
-
11
-
-
0035146653
-
Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS Cohort Study
-
Kleeberger CA, Phair JP, Strathdee SA, et al. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001;26:82-92.
-
(2001)
J Acquir Immune Defic Syndr
, vol.26
, pp. 82-92
-
-
Kleeberger, C.A.1
Phair, J.P.2
Strathdee, S.A.3
-
12
-
-
0033391009
-
Sociodemographic and psycological variables influencing adherence to antiretroviral therapy
-
Gordillo V, del Amo J, Soriano V, et al. Sociodemographic and psycological variables influencing adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 1999;13:1763-1769.
-
(1999)
J Acquir Immune Defic Syndr
, vol.13
, pp. 1763-1769
-
-
Gordillo, V.1
del Amo, J.2
Soriano, V.3
-
13
-
-
33846628608
-
Adherence in antiretroviral therapy: A review of qualitative studies
-
Vervoort SCJM, Borleffs JCC, Hoepelman AIM, et al. Adherence in antiretroviral therapy: a review of qualitative studies. AIDS. 2007;21:271-281.
-
(2007)
AIDS
, vol.21
, pp. 271-281
-
-
Vervoort, S.C.J.M.1
Borleffs, J.C.C.2
Hoepelman, A.I.M.3
-
14
-
-
0036749951
-
Simpler regimens may enhance adherence to antiretrovirals in HIV infected patients
-
Maggiolo F, Ripamonti D, Arici C, et al. Simpler regimens may enhance adherence to antiretrovirals in HIV infected patients. HIV Clin Trials. 2002;5:371-378.
-
(2002)
HIV Clin Trials
, vol.5
, pp. 371-378
-
-
Maggiolo, F.1
Ripamonti, D.2
Arici, C.3
-
15
-
-
0038555460
-
Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than those receiving protease inhibitor-containing regimens
-
Trotta MP, Ammassari A, Cozzi-Lepri A, et al. Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than those receiving protease inhibitor-containing regimens. AIDS. 2003;17: 1099-1102.
-
(2003)
AIDS
, vol.17
, pp. 1099-1102
-
-
Trotta, M.P.1
Ammassari, A.2
Cozzi-Lepri, A.3
-
16
-
-
0036615658
-
Adherence to antiretroviral therapy and outcomes in HIV infected patients enrolled in an induction/ maintenance randomized trial
-
Flandre P, Peytavin G, Meifreddy V, et al. Adherence to antiretroviral therapy and outcomes in HIV infected patients enrolled in an induction/ maintenance randomized trial. Antivir Ther. 2002;7:113-121.
-
(2002)
Antivir Ther
, vol.7
, pp. 113-121
-
-
Flandre, P.1
Peytavin, G.2
Meifreddy, V.3
-
17
-
-
3042775345
-
Perspectives on adherence and simplicity of HIV-infected patients on antiretroviral therapy. Self-report of the relative importance of multiple attributes of Highly Active Antiretroviral Therapy (HAART) regimens in predicting adherence
-
Stone VE, Jordan J, Tolson J, et al. Perspectives on adherence and simplicity of HIV-infected patients on antiretroviral therapy. Self-report of the relative importance of multiple attributes of Highly Active Antiretroviral Therapy (HAART) regimens in predicting adherence. J Acquir Immune Defic Syndr. 2004;36:808-816.
-
(2004)
J Acquir Immune Defic Syndr
, vol.36
, pp. 808-816
-
-
Stone, V.E.1
Jordan, J.2
Tolson, J.3
-
18
-
-
45949108248
-
Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus more frequent regimen improves adherence while maintaining viral suppression
-
Boyle B, Jayaweera D, Witt MD, et al. Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus more frequent regimen improves adherence while maintaining viral suppression. HIV Clin Trials. 2008;9:164-176.
-
(2008)
HIV Clin Trials
, vol.9
, pp. 164-176
-
-
Boyle, B.1
Jayaweera, D.2
Witt, M.D.3
-
19
-
-
0033496346
-
Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy
-
Singh N, Berman SM, Swindells S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis. 1999;29:824-830.
-
(1999)
Clin Infect Dis
, vol.29
, pp. 824-830
-
-
Singh, N.1
Berman, S.M.2
Swindells, S.3
-
20
-
-
37349036469
-
HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time
-
Holmes WC, Bilker WB, Wang H, et al. HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time. J Acquir Immune Defic Syndr. 2007;46:323-327.
-
(2007)
J Acquir Immune Defic Syndr
, vol.46
, pp. 323-327
-
-
Holmes, W.C.1
Bilker, W.B.2
Wang, H.3
-
21
-
-
10244222219
-
A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV
-
Benson CA, van der Horst C, LaMarca A, et al. A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV. AIDS. 2004;18:2269-2276.
-
(2004)
AIDS
, vol.18
, pp. 2269-2276
-
-
Benson, C.A.1
van der Horst, C.2
LaMarca, A.3
-
22
-
-
0027569430
-
The MOS 36-Item Short-Form Health Survey (SF-36) Psychometric and clinical tests of validity in measuring physical and mental health constructs
-
McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36) Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247-263.
-
(1993)
Med Care
, vol.31
, pp. 247-263
-
-
McHorney, C.A.1
Ware Jr., J.E.2
Raczek, A.E.3
-
23
-
-
0020574134
-
Studies with different types of visual analogue scales for measurement of pain
-
Sriwatanakul K, Kelvie W, Lasagna L, et al. Studies with different types of visual analogue scales for measurement of pain. Clin Pharmacol Ther. 1983;34:234-239.
-
(1983)
Clin Pharmacol Ther
, vol.34
, pp. 234-239
-
-
Sriwatanakul, K.1
Kelvie, W.2
Lasagna, L.3
-
24
-
-
2542565696
-
Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale
-
Giordano TP, Guzman D, Clark R, et al. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5:74-79.
-
(2004)
HIV Clin Trials
, vol.5
, pp. 74-79
-
-
Giordano, T.P.1
Guzman, D.2
Clark, R.3
-
25
-
-
12144288676
-
Adherence, quality of life, and general satisfaction with co-formulated zidovudine, lamivudine, and abacavir on antiretroviral-experienced patients
-
Clotet B, Carmena J, Pulido F, et al. Adherence, quality of life, and general satisfaction with co-formulated zidovudine, lamivudine, and abacavir on antiretroviral-experienced patients. HIV Clin Trials. 2004; 5:33-39.
-
(2004)
HIV Clin Trials
, vol.5
, pp. 33-39
-
-
Clotet, B.1
Carmena, J.2
Pulido, F.3
-
26
-
-
0345458936
-
1993 revised system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention. 1993 revised system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR. 1992;41:9-12.
-
(1992)
MMWR
, vol.41
, pp. 9-12
-
-
-
27
-
-
33645103497
-
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients
-
The Swiss HIV Cohort study
-
Glass TR, De Geest S, Weber R, et al. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients. The Swiss HIV Cohort study. J Acquir Immune Defic Syndr. 2006;41:385-392.
-
(2006)
J Acquir Immune Defic Syndr
, vol.41
, pp. 385-392
-
-
Glass, T.R.1
De Geest, S.2
Weber, R.3
-
28
-
-
0033773461
-
The concept of clinically meaningful in healthrelated quality-of-life research. How meaningful is it?
-
Hays RD, Woolley JM. The concept of clinically meaningful in healthrelated quality-of-life research. How meaningful is it? Pharmacoeconomics. 2000;18:419-423.
-
(2000)
Pharmacoeconomics
, vol.18
, pp. 419-423
-
-
Hays, R.D.1
Woolley, J.M.2
-
29
-
-
52049088798
-
Antiretroviral failure despite high levels of adherence: Discordant adherence-response relationship in Botswana
-
Bisson GP, Rowh A, Weinstein R, et al. Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana. J Acquir Immune Defic Syndr. 2008;49:107-110.
-
(2008)
J Acquir Immune Defic Syndr
, vol.49
, pp. 107-110
-
-
Bisson, G.P.1
Rowh, A.2
Weinstein, R.3
-
30
-
-
33745466408
-
A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART
-
Golin CE, Earp J, Tien HC, et al. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr. 2006;42:42-51.
-
(2006)
J Acquir Immune Defic Syndr
, vol.42
, pp. 42-51
-
-
Golin, C.E.1
Earp, J.2
Tien, H.C.3
-
31
-
-
0035894169
-
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection
-
Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr. 2001;28:445-449.
-
(2001)
J Acquir Immune Defic Syndr
, vol.28
, pp. 445-449
-
-
Ammassari, A.1
Murri, R.2
Pezzotti, P.3
-
32
-
-
0036798791
-
Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy
-
Heath KV, Singer J, O'Shaughnessy MV, et al. Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31:211-217.
-
(2002)
J Acquir Immune Defic Syndr
, vol.31
, pp. 211-217
-
-
Heath, K.V.1
Singer, J.2
O'Shaughnessy, M.V.3
-
33
-
-
40749143163
-
Mild-to moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals
-
Mannheimer SB, Wold N, Gardner EM, et al. Mild-to moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals. Clin Infect Dis. 2008;46:941-945.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 941-945
-
-
Mannheimer, S.B.1
Wold, N.2
Gardner, E.M.3
-
34
-
-
46049096485
-
Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
-
Shen L, Peterson S, Sedaghat AR, et al. Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs. Nat Med. 2008;14:762-766.
-
(2008)
Nat Med
, vol.14
, pp. 762-766
-
-
Shen, L.1
Peterson, S.2
Sedaghat, A.R.3
-
35
-
-
67649185287
-
Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients
-
DeJesus E, Young B, Morales-Ramirez JO, et al. Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients. J Acquir Immune Defic Syndr. 2009;51:163-174.
-
(2009)
J Acquir Immune Defic Syndr
, vol.51
, pp. 163-174
-
-
DeJesus, E.1
Young, B.2
Morales-Ramirez, J.O.3
-
36
-
-
37349036469
-
HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time
-
Holmes WC, Bilker WB, Wang H, et al. HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time. J Acquir Immune Defic Syndr. 2007;46:323-327.
-
(2007)
J Acquir Immune Defic Syndr
, vol.46
, pp. 323-327
-
-
Holmes, W.C.1
Bilker, W.B.2
Wang, H.3
|